|
Market Closed -
Nasdaq
04:00:00 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 170.68 USD | +3.06% |
|
+9.38% | +39.06% |
| Oct. 30 | Gilead's HIV Franchise Supports Growth Outlook, RBC Says | MT |
| Oct. 30 | UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy Rating | MT |
| Market Cap | 212B 190B 175B 158B 296B 20,101B 301B 2,077B 835B 10,570B 794B 777B 33,347B | P/E 2026 * |
-41.3x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 233B 209B 192B 174B 326B 22,121B 331B 2,286B 919B 11,633B 874B 856B 36,698B | EV / Sales 2026 * |
7.47x | EV / Sales 2027 * | 6.69x |
| Free-Float |
99.8% | Yield 2026 * |
1.93% | Yield 2027 * | 1.97% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
Xetra
| GIS | Delayed | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
London S.E.
| 0QYQ | Delayed | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +3.06% | ||
| 1 week | +9.38% | ||
| Current month | +14.51% | ||
| 1 month | +14.51% | ||
| 3 months | +30.01% | ||
| 6 months | +30.45% | ||
| Current year | +39.06% |
| 1 week | 155.76 |  | 175.65 |
| 1 month | 142.6 | | 175.65 |
| Current year | 116.88 | | 175.65 |
| 1 year | 116.88 | | 175.65 |
| 3 years | 62.07 | | 175.65 |
| 5 years | 57.16 | | 175.65 |
| 10 years | 56.56 | | 175.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 10/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 10/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +2.21% | +2.29% | -17.54% | -60.73% | 176B | |
| Average | +2.10% | +5.54% | +40.18% | +68.75% | 443.77B | |
| Weighted average by Cap. | +2.01% | +6.43% | +48.17% | +92.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.2B 27.96B 25.73B 23.3B 43.59B 2,962B 44.38B 306B 123B 1,558B 117B 115B 4,914B | 33.46B 29.99B 27.6B 24.99B 46.75B 3,177B 47.6B 328B 132B 1,671B 126B 123B 5,271B |
| Net income | -4.98B -4.46B -4.11B -3.72B -6.95B -473B -7.08B -48.84B -19.63B -249B -18.68B -18.28B -784B | 10.58B 9.48B 8.73B 7.9B 14.78B 1,005B 15.05B 104B 41.72B 528B 39.71B 38.86B 1,667B |
| Net Debt | 21.27B 19.07B 17.55B 15.89B 29.72B 2,020B 30.26B 209B 83.88B 1,062B 79.83B 78.12B 3,351B | 12.21B 10.95B 10.08B 9.12B 17.07B 1,160B 17.37B 120B 48.16B 610B 45.83B 44.86B 1,924B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $170.68 | +3.06% | 11,427,256 |
| 26-10-29 | $165.61 | +4.03% | 8,431,613 |
| 26-10-28 | $159.20 | +0.08% | 5,002,342 |
| 26-10-27 | $159.08 | +0.25% | 4,934,514 |
| 26-10-26 | $158.69 | +1.70% | 6,047,660 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
